Trials / Conditions / Ann Arbor Stage IIB Hodgkin Lymphoma
Ann Arbor Stage IIB Hodgkin Lymphoma
5 registered clinical trials studyying Ann Arbor Stage IIB Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma NCT03712202 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II NCT03233347 | Academic and Community Cancer Research United | Phase 2 |
| Active Not Recruiting | Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma NCT02758717 | Academic and Community Cancer Research United | Phase 2 |
| Active Not Recruiting | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage I NCT02166463 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin NCT01771107 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |